About Jim Borneman
Jim Borneman is an executive officer at Bryn Pharma.
Jim Borneman first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Jim Borneman in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Jim Borneman works with at each company, as listed on that company's latest Form D.
Bryn Pharma, Inc. · Form D, Aug 14, 2025
AW
Anne Whitaker
Director
MK
Michael Kaseta
Director
JH
Jeff Hartness
Director
SH
Steven Hartman
Director
JZ
Joshua Ziel
Executive officer
ML
Michelle Lobel
Director
SK
MR
Marc Rapaport
Director
LL
Lisa Licht
Director
SL
Sandra Loreaux
Director
KD
Kate Soper Diaz
Director